Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Daniel Dalcin1, Scott A Halperin2

  • 1Département de médecine de familiale (Dalcin), Université Western, London, Ont.; département de pédiatrie et département de microbiologie et d'immunologie (Halperin), Centre canadien de vaccinologie, Université Dalhousie; Centre de santé IWK et Régie de la santé de la Nouvelle-Écosse (Halperin), Halifax, N.-É ddalcin@nosm.ca.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|January 22, 2024
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.

medRxiv : the preprint server for health sciences·2026
Same author

Epidemiology and severity of pediatric influenza hospitalizations before and during the COVID-19 pandemic: a surveillance study of the Canadian immunization monitoring program (IMPACT), 2012-2023.

Lancet regional health. Americas·2026
Same author

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

Human vaccines & immunotherapeutics·2026
Same author

Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trial.

Vaccine·2026
Same author

A Systematic Review and Meta-Analysis of the Effectiveness of Process Interventions for Reducing Distress during Vaccine Injections.

The Clinical journal of pain·2026
Same author

Adenovirus type 5 vector-based COVID-19 vaccine does not increase the likelihood of HIV infection.

Vaccine·2026
Same journal

Rheumatoid synovitis of the elbow mimicking rheumatoid nodule.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

What pool closures in Canada mean for health.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Fatal rabies in a child.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Otitis externa.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
See all related articles